Literature DB >> 15382307

State-of-the-art screening for lung cancer (part 1): the chest radiograph.

Matthew Freedman1.   

Abstract

The chest radiographic methods used in prior studies of lung cancer screening and in current prospective clinical trials of lung cancer screening do not incorporate, as part of their prospective design, the newer methods available for the detection of lung nodules. DR, image processing, ES, and CAD have been shown to enhance lung nodule detection. TS is a promising method but with less supporting data currently available. These techniques, alone or in combination, do not equal the nodule detection capability of lung CT, but they are likely to benefit patients having CXRs for other clinically indicated purposes and when the detection of a nodule is incidental to the clinical indication for the radiographic study.

Entities:  

Mesh:

Year:  2004        PMID: 15382307     DOI: 10.1016/S1547-4127(04)00036-2

Source DB:  PubMed          Journal:  Thorac Surg Clin            Impact factor:   1.750


  5 in total

1.  Electromagnetic navigation diagnostic bronchoscopy: a prospective study.

Authors:  Thomas R Gildea; Peter J Mazzone; Demet Karnak; Moulay Meziane; Atul C Mehta
Journal:  Am J Respir Crit Care Med       Date:  2006-07-27       Impact factor: 21.405

2.  Does computer-aided diagnosis for lung tumors change satisfaction of search in chest radiography?

Authors:  Kevin S Berbaum; Robert T Caldwell; Kevin M Schartz; Brad H Thompson; E A Franken
Journal:  Acad Radiol       Date:  2007-09       Impact factor: 3.173

3.  Role of chest radiographs in early lung cancer detection.

Authors:  Junghyun Kim; Kwan Hyoung Kim
Journal:  Transl Lung Cancer Res       Date:  2020-06

Review 4.  Lung cancer screening-don't forget the chest radiograph.

Authors:  Johannes Gossner
Journal:  World J Radiol       Date:  2014-04-28

5.  A mathematical model of case-ascertainment bias: Applied to case-control studies nested within a randomized screening trial.

Authors:  Rick J Jansen; Bruce H Alexander; Richard B Hayes; Anthony B Miller; Sholom Wacholder; Timothy R Church
Journal:  PLoS One       Date:  2018-03-19       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.